C & RF Srl - Meklēšanas rezultāti

p3-lubodrive rf

ecolab deutschland gmbh -

Eiropas Savienība - latviešu - EMA (European Medicines Agency)

xeljanz

pfizer europe ma eeig - tofacitinibs - artrīts, reimatoīds - imūnsupresanti - rheumatoid arthritistofacitinib in combination with methotrexate (mtx) is indicated for the treatment of moderate to severe active rheumatoid arthritis (ra) in adult patients who have responded inadequately to, or who are intolerant to one or more disease-modifying antirheumatic drugs (dmards) (see section 5. tofacitinib can be given as monotherapy in case of intolerance to mtx or when treatment with mtx is inappropriate (see sections 4. 4 un 4. psoriatic arthritistofacitinib in combination with mtx is indicated for the treatment of active psoriatic arthritis (psa) in adult patients who have had an inadequate response or who have been intolerant to a prior disease modifying antirheumatic drug (dmard) therapy (see section 5. ulcerative colitistofacitinib is indicated for the treatment of adult patients with moderately to severely active ulcerative colitis (uc) who have had an inadequate response, lost response, or were intolerant to either conventional therapy or a biologic agent (see section 5. tofacitinib is indicated for the treatment of active polyarticular juvenile idiopathic arthritis (rheumatoid factor positive [rf+] or negative [rf-] polyarthritis and extended oligoarthritis), and juvenile psoriatic arthritis (psa) in patients 2 years of age and older, who have responded inadequately to previous therapy with disease modifying antirheumatic drugs (dmards). tofacitinib can be given in combination with methotrexate (mtx) or as monotherapy in case of intolerance to mtx or where continued treatment with mtx is inappropriate. ankylosing spondylitistofacitinib is indicated for the treatment of adult patients with active ankylosing spondylitis (as) who have responded inadequately to conventional therapy.

Latvija - latviešu - Zāļu valsts aģentūra

solpadeine tabletes

perrigo romania srl, romania - paracetamolum, codeini phosphas hemihydricus, kofeīns - tablete - 500 mg/8 mg/30 mg

Latvija - latviešu - Zāļu valsts aģentūra

nurofen bērniem ar apelsīnu garšu 100 mg/5 ml suspensija iekšķīgai lietošanai

reckitt benckiser (romania) srl, romania - ibuprofēns - suspensija iekšķīgai lietošanai - 100 mg/5 ml

Latvija - latviešu - Pārtikas un veterinārais dienests, Zemkopības ministrija

eie® neogascolic (2017.) cits, šķīdums

adamàh srl. - cits, šķīdums

Latvija - latviešu - Pārtikas un veterinārais dienests, Zemkopības ministrija

eie® gascolic 2 (2017.) cits, šķīdums

adamàh srl. - cits, šķīdums